Abstract:Skeletal muscle wasting, whether related to physiological ageing, muscle disuse or to an underlying chronic disease, is a key determinant to quality of life and mortality. However, cellular basis responsible for increased catabolism in myocytes often remains unclear. Although myocytes represent the vast majority of skeletal muscle cellular population, they are surrounded by numerous cells with various functions. Animal models, mostly rodents, can help to decipher the mechanisms behind this highly dynamic process, by allowing access to every muscle as well as time‐course studies. Satellite cells (SCs) play a crucial role in muscle regeneration, within a niche also composed of fibroblasts and vascular and immune cells. Their proliferation and differentiation is altered in several models of muscle wasting such as cancer, chronic kidney disease or chronic obstructive pulmonary disease (COPD). Fibro‐adipogenic progenitor cells are also responsible for functional muscle growth and repair and are associated in disease to muscle fibrosis such as in chronic kidney disease. Other cells have recently proven to have direct myogenic potential, such as pericytes. Outside their role in angiogenesis, endothelial cells and pericytes also participate to healthy muscle homoeostasis by promoting SC pool maintenance (so‐called myogenesis–angiogenesis coupling). Their role in chronic diseases muscle wasting has been less studied. Immune cells are pivotal for muscle repair after injury: Macrophages undergo a transition from the M1 to the M2 state along with the transition between the inflammatory and resolutive phase of muscle repair. T regulatory lymphocytes promote and regulate this transition and are also able to activate SC proliferation and differentiation. Neural cells such as terminal Schwann cells, motor neurons and kranocytes are notably implicated in age‐related sarcopenia. Last, newly identified cells in skeletal muscle, such as telocytes or interstitial tenocytes could play a role in tissular homoeostasis. We also put a special focus on cellular alterations occurring in COPD, a chronic and highly prevalent respiratory disease mainly linked to tobacco smoke exposure, where muscle wasting is strongly associated with increased mortality, and discuss the pros and cons of animal models versus human studies in this context. Finally, we discuss resident cells metabolism and present future promising leads for research, including the use of muscle organoids.

Exploring cellular senescence in the musculoskeletal system: any insights for biomarkers discovery?

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Musculoskeletal imaging of senescence

Cellular senescence in skeletal disease: mechanisms and treatment

Cellular Senescence and Inflammaging in the Bone: Pathways, Genetics, Anti-Aging Strategies and Interventions

Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis

The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.

Characterization of cellular senescence in aging skeletal muscle

Age-related Changes in Bone Marrow Mesenchymal Stromal Cells

Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction

Molecular and Cellular Aspects of Sarcopenia, Muscle Healthy Aging and Physical Conditioning in the Elderly

Skeletal Aging and Osteoporosis: Cellular Senescence and Beyond

Running on empty: Exploring stem cell exhaustion in geriatric musculoskeletal disease

Determinants of Muscle and Bone Aging

Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models

Identification of Senescent Cells in the Bone Microenvironment

Cellular senescence: is the problem a solution for muscle repair?

Senescence of skeletal stem cells and their contribution to age-related bone loss

Multimodal cell atlas of the ageing human skeletal muscle

Dietary interventions and molecular mechanisms for healthy musculoskeletal aging

Cellular senescence as a key factor in osteoporosis: the role of SIRT1